Eligibility Asthma NCT00187499

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00187499
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
male and female patients with a history of asthma between the ages of 18 and 70 years.
Descripción

asthma and age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004096
UMLS CUI [2]
C0001779
pc20fev1 methacholine ≤ 8.0 mg/ml.
Descripción

pc20fev1 methacholine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1714620
at least one of the following symptoms, beta agonist use, or fev1 criteria:
Descripción

ID.3

Tipo de datos

boolean

asthma symptoms on at least two days per week or beta agonist use on at least two days per week or fev1 < 85% predicted
Descripción

asthma symptoms

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C1457887
UMLS CUI [2]
C0001644
UMLS CUI [3]
C0748133
subjects must be non-smokers (patients who have never smoked or patients who have not smoked for 1 year and have a total pack-year smoking history < 15 packs).
Descripción

non-smoker

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0337672
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of oral or inhaled steroid use in the past 4 weeks.
Descripción

steroid

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0038317
UMLS CUI [1,2]
C0040223
fev1 < 60% predicted.
Descripción

fev1

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0748133
lung disease other than asthma.
Descripción

lung disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0024115
patients with a history of a respiratory tract infection in the 4 weeks preceding the study.
Descripción

respiratory tract infection

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0035243
UMLS CUI [1,2]
C0040223
patients who have experienced a significant exacerbation in their asthma in the 6 weeks prior to the study.
Descripción

asthma exacerbation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0349790
UMLS CUI [1,2]
C0040223
patients receiving hyposensitization therapy with the exception of those who are on a stable dose for the last three months.
Descripción

hyposensitization

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0178702
patients with cardiovascular disease (active) peptic ulcer disease or diabetes mellitus.
Descripción

cardiovascular disease, peptic ulcer diseases or diabetes mellitus

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0030920
UMLS CUI [3]
C0011849
females who are lactating or who are pregnant.
Descripción

pregnancy or lactation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147

Similar models

Eligibility Asthma NCT00187499

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00187499
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
asthma and age
Item
male and female patients with a history of asthma between the ages of 18 and 70 years.
boolean
C0004096 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
pc20fev1 methacholine
Item
pc20fev1 methacholine ≤ 8.0 mg/ml.
boolean
C1714620 (UMLS CUI [1])
ID.3
Item
at least one of the following symptoms, beta agonist use, or fev1 criteria:
boolean
asthma symptoms
Item
asthma symptoms on at least two days per week or beta agonist use on at least two days per week or fev1 < 85% predicted
boolean
C0004096 (UMLS CUI [1,1])
C1457887 (UMLS CUI [1,2])
C0001644 (UMLS CUI [2])
C0748133 (UMLS CUI [3])
non-smoker
Item
subjects must be non-smokers (patients who have never smoked or patients who have not smoked for 1 year and have a total pack-year smoking history < 15 packs).
boolean
C0337672 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
steroid
Item
history of oral or inhaled steroid use in the past 4 weeks.
boolean
C0038317 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
fev1
Item
fev1 < 60% predicted.
boolean
C0748133 (UMLS CUI [1])
lung disease
Item
lung disease other than asthma.
boolean
C0024115 (UMLS CUI [1])
respiratory tract infection
Item
patients with a history of a respiratory tract infection in the 4 weeks preceding the study.
boolean
C0035243 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
asthma exacerbation
Item
patients who have experienced a significant exacerbation in their asthma in the 6 weeks prior to the study.
boolean
C0349790 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
hyposensitization
Item
patients receiving hyposensitization therapy with the exception of those who are on a stable dose for the last three months.
boolean
C0178702 (UMLS CUI [1])
cardiovascular disease, peptic ulcer diseases or diabetes mellitus
Item
patients with cardiovascular disease (active) peptic ulcer disease or diabetes mellitus.
boolean
C0007222 (UMLS CUI [1])
C0030920 (UMLS CUI [2])
C0011849 (UMLS CUI [3])
pregnancy or lactation
Item
females who are lactating or who are pregnant.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])